75 related articles for article (PubMed ID: 3402031)
1. Pharmacokinetics of N-nitrosodimethylamine in swine.
Gombar CT; Harrington GW; Pylypiw HM; Bevill RF; Thurmon JC; Nelson DR; Magee PN
Carcinogenesis; 1988 Aug; 9(8):1351-4. PubMed ID: 3402031
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of N-nitrosodimethylamine in beagles.
Gombar CT; Pylypiw HM; Harrington GW
Cancer Res; 1987 Jan; 47(2):343-7. PubMed ID: 3791224
[TBL] [Abstract][Full Text] [Related]
3. Interspecies scaling of the pharmacokinetics of N-nitrosodimethylamine.
Gombar CT; Harrington GW; Pylypiw HM; Anderson LM; Palmer AE; Rice JM; Magee PN; Burak ES
Cancer Res; 1990 Jul; 50(14):4366-70. PubMed ID: 2364390
[TBL] [Abstract][Full Text] [Related]
4. Low-dose in vivo pharmacokinetic and deuterium isotope effect studies of N-nitrosodimethylamine in rats.
Mico BA; Swagzdis JE; Hu HS; Keefer LK; Oldfield NF; Garland WA
Cancer Res; 1985 Dec; 45(12 Pt 1):6280-5. PubMed ID: 4063978
[TBL] [Abstract][Full Text] [Related]
5. Toxicokinetics of N-nitrosodimethylamine in the Syrian golden hamster.
Streeter AJ; Nims RW; Wu PP; Logsdon DL
Arch Toxicol; 1990; 64(7):562-6. PubMed ID: 2073129
[TBL] [Abstract][Full Text] [Related]
6. Suppression of in vivo clearance of N-nitrosodimethylamine in mice by cotreatment with ethanol.
Anderson LM; Koseniauskas R; Burak ES; Logsdon DL; Carter JP; Driver CL; Gombar CT; Magee PN; Harrington GW
Drug Metab Dispos; 1994; 22(1):43-9. PubMed ID: 8149888
[TBL] [Abstract][Full Text] [Related]
7. Clearance of N-nitrosodimethylamine and N-nitrosodiethylamine by the perfused rat liver. Relationship to the Km and Vmax for nitrosamine metabolism.
Graves RJ; Swann PF
Biochem Pharmacol; 1993 Mar; 45(5):983-9. PubMed ID: 8461051
[TBL] [Abstract][Full Text] [Related]
8. Salivary excretion of N-nitrosodimethylamine in dogs.
Hino K; Karaki Y; Hatanaka T; Sakamoto T; Tsukada K
Eur J Cancer Prev; 2000 Aug; 9(4):275-81. PubMed ID: 10958331
[TBL] [Abstract][Full Text] [Related]
9. The formation, disposition, and hepatic metabolism of dimethylnitrosamine in the pig.
Harrington GW; Magee PN; Pylypiw HM; Kozeniauskas R; Bevill RF; Nelson DR; Thurmon JC
Drug Metab Dispos; 1990; 18(5):626-31. PubMed ID: 1981711
[TBL] [Abstract][Full Text] [Related]
10. Reduced blood clearance and increased urinary excretion of N-nitrosodimethylamine in patas monkeys exposed to ethanol or isopropyl alcohol.
Anderson LM; Koseniauskas R; Burak ES; Moskal TJ; Gombar CT; Phillips JM; Sansone EB; Keimig S; Magee PN; Rice JM
Cancer Res; 1992 Mar; 52(6):1463-8. PubMed ID: 1540953
[TBL] [Abstract][Full Text] [Related]
11. Metabolic denitrosation of N-nitrosodimethylamine in vivo in the rat.
Streeter AJ; Nims RW; Sheffels PR; Heur YH; Yang CS; Mico BA; Gombar CT; Keefer LK
Cancer Res; 1990 Feb; 50(4):1144-50. PubMed ID: 2297762
[TBL] [Abstract][Full Text] [Related]
12. Estimation of the fraction of the dose of N-nitrosodimethylamine metabolized to methylamine in rats.
Burak ES; Harrington GW; Koseniauskas R; Gombar CT
Cancer Lett; 1991 Jun; 58(1-2):1-6. PubMed ID: 2049775
[TBL] [Abstract][Full Text] [Related]
13. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of N-nitrosodimethylamine metabolism in rats by ether anesthesia.
Keefer LK; Garland WA; Oldfield NF; Swagzdis JE; Mico BA
Cancer Res; 1985 Nov; 45(11 Pt 1):5457-60. PubMed ID: 4053020
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of nocloprost in human volunteers and its relation to dose.
Tüber U; Brudny-Klöppel M; Jakobs U; Madetzki C; Mahler M
Eur J Clin Pharmacol; 1993; 44(5):497-500. PubMed ID: 8359191
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
18. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease.
Bramer SL; Forbes WP; Mallikaarjun S
Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882
[TBL] [Abstract][Full Text] [Related]
19. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
Säwe J
Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
